Author

Shivendra Vikram Singh

St. Jude Children's Research HospitalORCID 0000-0002-4153-8056Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew Cortes· 1 shared Andrew Jackson MurphyiD· 1 shared Andrew M. DavidoffiD· 1 shared Burgess B. FreemaniD· 1 shared Christopher L. MortoniD· 1 shared Evon PooniD· 1 shared Gregory H. TurneriD· 1 shared Hongjian JiniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrew Cortes

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RBM39 degrader invigorates natural killer cells to eradicate neuroblastoma despite cancer cell plasticity

Shivendra Vikram Singh, Jie Fang, Hongjian Jin, Lee-Ann Van de Velde, Andrew Cortes, Jiani Chen, Sivaraman Natarajan, Evon Poon, Qiong Wu, Christopher L. Morton, Mary A. Woolard, Waise Quarni, Jacob A. Steele, Jon P. Connelly, Liusheng He, , Jun J.J. Yang

This study shows that targeting RBM39 with indisulam promotes natural killer cell activity and eradicates neuroblastoma regardless of cellular state plasticity.

Nature Communications · Sep 17, 2025Peer-reviewedCancer Biology